Net Pals Net Pals
Arama Sonuçları
Tüm Sonuçları Gör
  • Katıl
    Giriş yapın
    Başvur
    Site içinde arama yapın
    Night Mode

Site içinde arama yapın

Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek

  • Web sayfası bildirimcisi
  • EXPLORE
  • Sayfalar
  • Gruplar
  • Events
  • Reels
  • Blogs
  • Market
  • Offers
  • Jobs
  • Yazı
  • Blogs
  • Kullanıcılar
  • Sayfalar
  • Gruplar
  • Events
  • anjushinde13 bir ses eklendi Health
    2026-06-10 11:30:18 - Translate -
    SGLT2 Inhibitors Market Gains Momentum with Growing Adoption of Advanced Therapies
    SGLT2 Inhibitors Market for Diabetes Treatment Market is being significantly propelled by the well-documented cardiovascular and renal protective benefits of SGLT2 inhibitors beyond glycemic management. Landmark clinical trials such as EMPA-REG OUTCOME, CANVAS, and DECLARE-TIMI 58 have demonstrated statistically significant reductions in major adverse cardiovascular events (MACE),...
    0 Yorumlar 0 hisse senetleri 395 Views 0 önizleme
    Please log in to like, share and comment!
  • pratap11 bir ses eklendi Other
    2026-08-17 12:10:43 - Translate -
    SGLT2 Inhibitors Market: Cardiometabolic Health, Drug Innovation & Emerging Opportunities
    According to a new report by Polaris Market Research, the global SGLT2 Inhibitors market was valued at USD 18.32 billion in 2025 and is projected to reach USD 33.51 billion by 2034, expanding at a CAGR of 6.90% over the forecast period. Growth is underpinned by rising cardiorenal treatment adoption, expanding type 2 diabetes prevalence, and accelerating new drug approvals across key...
    0 Yorumlar 0 hisse senetleri 6 Views 0 önizleme
    Please log in to like, share and comment!
  • Subhayan2 bir ses eklendi Other
    2026-06-18 09:38:01 - Translate -
    Global Diabetes Drugs Market Growing at 12.1% CAGR Through 2032
    According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...
    0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
    Please log in to like, share and comment!
© 2026 Net Pals Turkish
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Koşullar Gizlilik Cookies Acceptable Use Contact Us Rehber